NCNA

NuCana plc

3.01 USD
-0.02 (-0.66%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NuCana plc stock is up 1.69% since 30 days ago. The next earnings date is Aug 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 July’s closed higher than June.

About NuCana plc

NuCana plc engages in the development of products for the treatment of cancer. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil.